NO994900D0 - Forbindelser - Google Patents

Forbindelser

Info

Publication number
NO994900D0
NO994900D0 NO994900A NO994900A NO994900D0 NO 994900 D0 NO994900 D0 NO 994900D0 NO 994900 A NO994900 A NO 994900A NO 994900 A NO994900 A NO 994900A NO 994900 D0 NO994900 D0 NO 994900D0
Authority
NO
Norway
Prior art keywords
compounds
Prior art date
Application number
NO994900A
Other languages
English (en)
Other versions
NO994900L (no
Inventor
Thomas Mcinally
Alan Tinker
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO994900D0 publication Critical patent/NO994900D0/no
Publication of NO994900L publication Critical patent/NO994900L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO994900A 1997-04-09 1999-10-08 Forbindelser NO994900L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9701304A SE9701304D0 (sv) 1997-04-09 1997-04-09 Compounds
PCT/SE1998/000641 WO1998045294A1 (en) 1997-04-09 1998-04-07 Compounds

Publications (2)

Publication Number Publication Date
NO994900D0 true NO994900D0 (no) 1999-10-08
NO994900L NO994900L (no) 1999-11-19

Family

ID=20406499

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994900A NO994900L (no) 1997-04-09 1999-10-08 Forbindelser

Country Status (21)

Country Link
US (1) US6303613B1 (no)
EP (1) EP0973772A1 (no)
JP (1) JP2001519805A (no)
KR (1) KR20010006143A (no)
CN (1) CN1259131A (no)
AU (1) AU7091098A (no)
BR (1) BR9807950A (no)
CA (1) CA2285388A1 (no)
CZ (1) CZ355199A3 (no)
EE (1) EE9900448A (no)
HU (1) HUP0001865A2 (no)
ID (1) ID23861A (no)
IL (1) IL132085A0 (no)
IS (1) IS5208A (no)
NO (1) NO994900L (no)
NZ (1) NZ338006A (no)
PL (1) PL336141A1 (no)
SE (1) SE9701304D0 (no)
SK (1) SK128999A3 (no)
TR (1) TR199902495T2 (no)
WO (1) WO1998045294A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
SE9901530D0 (sv) * 1999-04-28 1999-04-28 Astra Pharma Prod Novel compounds
JP2004503588A (ja) * 2000-07-13 2004-02-05 ファルマシア・コーポレーション 全身性疼痛および頭痛に対する選択的シクロオキシゲナーゼ−2阻害薬および血管調節化合物
PT1303265E (pt) 2000-07-20 2007-10-09 Lauras As ''utilização de inibidores da cox-2 como imuno-estimulantes, no tratamento do vih ou da sida''
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
JP2005532293A (ja) * 2002-04-18 2005-10-27 ファルマシア・コーポレーション シクロオキシゲナーゼ−2(cox2)阻害剤を用いたパーキンソン病の治療のための単剤療法
US20040034083A1 (en) * 2002-04-18 2004-02-19 Stephenson Diane T. Combination therapy for the treatment of Parkinson's disease with cyclooxygenase-2 (COX2) inhibitor(s)
AU2003260033A1 (en) * 2002-08-29 2004-03-19 Schering Aktiengesellschaft Methods of treating acute respiratory distress syndrome
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
EP1626961B1 (en) * 2003-05-17 2011-11-02 Korea Research Institute of Bioscience and Biotechnology Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
DE102005024012A1 (de) * 2005-05-20 2006-11-23 Grünenthal GmbH Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
SI1924264T1 (sl) * 2005-09-01 2013-12-31 F. Hoffmann-La Roche Ag Diaminopirimidini kot modulatorji p2x3 in p2x2/3
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
AU2009260899B2 (en) 2008-06-18 2012-02-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3403152A (en) * 1967-03-20 1968-09-24 Ciba Geigy Corp 1-aryl-4-imino-1, 2, 3, 4-tetrahydroquinazolines
US3483205A (en) * 1967-12-22 1969-12-09 Ciba Geigy Corp Bicyclic tetrahydropyrimidines
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination

Also Published As

Publication number Publication date
IL132085A0 (en) 2001-03-19
SE9701304D0 (sv) 1997-04-09
BR9807950A (pt) 2000-03-08
AU7091098A (en) 1998-10-30
CN1259131A (zh) 2000-07-05
EE9900448A (et) 2000-04-17
US6303613B1 (en) 2001-10-16
WO1998045294A1 (en) 1998-10-15
KR20010006143A (ko) 2001-01-26
ID23861A (id) 2000-05-25
NZ338006A (en) 2001-04-27
CZ355199A3 (cs) 2000-03-15
CA2285388A1 (en) 1998-10-15
JP2001519805A (ja) 2001-10-23
HUP0001865A2 (hu) 2001-01-29
EP0973772A1 (en) 2000-01-26
TR199902495T2 (xx) 2000-07-21
IS5208A (is) 1999-10-05
PL336141A1 (en) 2000-06-05
SK128999A3 (en) 2000-05-16
NO994900L (no) 1999-11-19
MX9909188A (en) 2001-07-01

Similar Documents

Publication Publication Date Title
PT860428E (pt) Compostos pirimidiona
IS5479A (is) Efnasambönd
IS5478A (is) Efnasambönd
IS5477A (is) Efnasambönd
ID22850A (id) Senyawa-senyawa pirazina
EE200000044A (et) Uued ühendid
NO994877D0 (no) Kalsilytiske forbindelser
EE200000321A (et) Uudsed ühendid
ID20323A (id) Senyawa-senyawa triazinilaminostilbena
EE9900448A (et) Ühendid
NO995404D0 (no) Forbindelser
NO996544D0 (no) Forbindelser
ID22983A (id) Senyawa-senyawa fluorometoksimino
IS5211A (is) Efnasambönd
DE69737634D1 (de) Insektizide oxadiazinverbindungen
SE9702775D0 (sv) Novel compounds
ID21202A (id) Senyawa heterosiklik
SE9701397D0 (sv) Compounds
ID18388A (id) Senyawa-senyawa heterosiklik
SE9701964D0 (sv) Compounds
SE9703225D0 (sv) new compounds
SE9702746D0 (sv) New compounds
SE9704839D0 (sv) New compounds
SE9704837D0 (sv) New compounds
SE9704838D0 (sv) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application